Article in American journal of public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07560046 (Combating Related Epidemics in HCV Through Simplified Testing and Treatment. A Cluster Randomized Trial of Point-of-care Hepatitis C Testing and Treatment Among Key Populations), which is not on this map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
NCT07560046 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation
Combating Related Epidemics in HCV Through Simplified Testing and Treatment. A Cluster Randomized Trial of Point-of-care Hepatitis C Testing and Treatment Among Key Populations
TypeinterventionalSponsorDuke UniversityRan2026 to 2030Enrolled1,280ConditionsHIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV), HEPATITIS C (HCV)ArmsCepheid GeneXpert HCV Test, Abbott Determine HIV - 1/2 Ag/Ab, Abbott Determine HbsAg 2, Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
4 authors.
Samuel R BuntingSamuel Bunting is with the Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL. Nitin Vidyasagar is with the Pritzker School of Medicine, University of Chicago. Allison Wilson and Aniruddha Hazra are with the Chicago Center for HIV Elimination, University of Chicago. Aniruddha Hazra is also with the Section of Infectious Diseases, Department of Medicine, University of Chicago.
Nitin VidyasagarSamuel Bunting is with the Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL. Nitin Vidyasagar is with the Pritzker School of Medicine, University of Chicago. Allison Wilson and Aniruddha Hazra are with the Chicago Center for HIV Elimination, University of Chicago. Aniruddha Hazra is also with the Section of Infectious Diseases, Department of Medicine, University of Chicago.
Allison P WilsonSamuel Bunting is with the Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL. Nitin Vidyasagar is with the Pritzker School of Medicine, University of Chicago. Allison Wilson and Aniruddha Hazra are with the Chicago Center for HIV Elimination, University of Chicago. Aniruddha Hazra is also with the Section of Infectious Diseases, Department of Medicine, University of Chicago.
Aniruddha HazraSamuel Bunting is with the Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL. Nitin Vidyasagar is with the Pritzker School of Medicine, University of Chicago. Allison Wilson and Aniruddha Hazra are with the Chicago Center for HIV Elimination, University of Chicago. Aniruddha Hazra is also with the Section of Infectious Diseases, Department of Medicine, University of Chicago.
Funding
The Brown Initiative in HIV and AIDS Clinical Research for Minority CommunitiesR25MH083620 · NIMH · MIRIAM HOSPITAL · PI NUNN, AMY STEWART · 2008 to 2025
$3.7M
NIMH NIH HHS R25 MH083620
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
HIV InfectionsPre-Exposure ProphylaxisAmbulatory Care FacilitiesCross-Sectional StudiesFemaleHumansMaleRetrospective StudiesSexual and Gender MinoritiesSubstance Abuse Treatment CentersSubstance-Related DisordersUnited States
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Preexposure Prophylaxis (PrEP) for HIV Prevention at Outpatient Substance Use Treatment Facilities, United States, 2021. · full record | OpenQuestion